BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. Food and Drug Administration Director of the Office of Orphan Products Development, as Vice President, Regulatory Policy and Patient Advocacy

  Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced the appointment of Gayatri R. Rao, M.D., J.D., as Vice President, Regulatory Policy and Patient Advocacy.

  May 15, 2018

   · 

  3 min read
• Business

  Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update

  Treated first subject in clinical trials of two Synthetic BioticTM medicines, SYNB1020 and SYNB1618; both studies expected to generate data in 2018

  May 15, 2018

   · 

  8 min read
• Business

  Aerpio Reports First Quarter 2018 Financial Results and Provides Company Update

  TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track

  May 15, 2018

   · 

  6 min read
• Business

  Aldeyra Therapeutics Announces First Quarter 2018 Financial Results

  Aldeyra is a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases

  May 15, 2018

   · 

  16 min read
• Biotech Bay

  Accuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and Care

  Check out the new site at www.accuray.com.

  May 15, 2018

   · 

  5 min read
• Business

  CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results

  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), today reported financial results for the first quarter and provided a review of recent accomplishments and anticipated upcoming milestones.

  May 15, 2018

   · 

  8 min read
• Business

  Concordia International Corp. Announces First Quarter 2018 Results

  First quarter 2018 revenue of $152 million

  May 15, 2018

   · 

  34 min read
• Business

  Alnylam Appoints Colleen Reitan to the Board of Directors

  Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the appointment of a veteran healthcare leader, Colleen Reitan, to Alnylam’s Board of Directors, effective June 1, 2018.

  May 15, 2018

   · 

  5 min read
• Business

  Acerus Reports First Quarter 2018 Financial Results

  Product revenues increased 60% to $1.6 million versus $1.0 million in the same prior year period

  May 15, 2018

   · 

  10 min read
• BioCapital

  REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation

  The company recognizes International MPS Awareness Day 2018 on May 15 and supports the 5th Annual Million Dollar Bike Ride for rare disease research

  May 15, 2018

   · 

  8 min read